Customized Therapeutic Area Conference/Symposium
Located on Stanford University’s iconic campus, Stanford University and Amgen jointly hosted an all-day symposium in August of 2017 at the Arrillaga Alumni Center, bringing together experts in genetics and atherosclerosis. Joining the Stanford School of Medicine mission of innovation and discovery, experts shared information on the role of human genetics in discovering targets and translating those targets into therapies. 150 attendees from Bay Area biotech, pharmaceutical, and academic institutions joined the conference which concluded in an hour-long networking event in the Ford Gardens.
Kiera Larsen, RN, BSN, of SCCR oversaw planning and coordination of the conference while Josh Knowles, MD, PhD, directed the scientific leadership. Stanford provides a unique environment for collaboration with one of the nation’s most prestigious basic science departments coupled with the School of Medicine’s renowned clinicians and educators.
SCCR welcomes the opportunity for collaboration on a shared area of interest and expertise. Please contact us to learn more.
SCCR collaborates with external partners to provide educational programs on your desired therapeutic area. We work with you to create a tailored and personalized agenda for members of your team and focus on an interactive learning style. We partner with Stanford faculty and medical educators and incorporate immersive and simulation-based learning to bridge classroom education to realistic clinical situations.
Over the last three years, SCCR has worked with Janssen Pharmaceuticals, providing one and two-day programs to better prepare the sales and marketing teams to understand the clinical needs of academic clinicians and their patients. In 2015, the program was centered on clinical decision making and transitions of care for patients with atrial fibrillation (AF).
In 2016, Janssen arrived at the Stanford campus to learn the etiology, pathophysiology, diagnosis and treatment of five key areas: peripheral arterial disease, coronary artery disease, heart failure, embolic stroke of undetermined source, and transcatheter aortic valve replacement. This 2-day program also included dedicated time in the Stanford Immersive Learning Center, where learners took advantage of hands-on training with portable echo machines, vascular access using a femoral line trainer, and practice performing the ankle brachial index.
In May of 2018, SCCR proudly partnered with the American College of Cardiology (ACC) to design and implement the third preceptorship program with Janssen Pharmaceuticals. This program, titled “CV Essentials,” was very similar in nature to the second program and focused on three cardiovascular disease states: peripheral arterial disease, coronary artery disease, and heart failure. The pathophysiology, diagnosis and evaluation, risk stratification, and interventional strategies for each topic were covered. Use of the Immersive Learning Center was also included in this program, where learners worked with simulators when learning about vascular access for interventional cardiology procedures and transthoracic echocardiograms.
SCCR welcomes additional collaborators from pharmaceutical and biotech companies as well as academic partners to share and advance knowledge in many therapeutic areas. We invite you to connect with us to learn more about these programs.